AndersonJLHalperinJLAlbertNM, et al. Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF/AHA guideline recommendations): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;127:1425–1443.
2.
SirignanoPMansourWd’AdamoA, et al. Early experience with a new concept of angioplasty nitinol-constrained balloon catheter (Chocolate®) in severely claudicant patients. Cardiovasc Intervent Radiol. 2018;41:377–384.
3.
GarciaLA.Endovascular therapy for femoropopliteal disease: drug-eluting stents are not the default therapy. Circulation. 2016;133:330–336.
4.
KayssiAAl-AtassiTOreopoulosG, et al. Drug-eluting balloon angioplasty versus uncoated balloon angioplasty for peripheral arterial disease of the lower limbs. Cochrane Database Syst Rev. 2016;(8):CD011319.
5.
MaleckisKDeeganPPoulsonW, et al. Comparison of femoropopliteal artery stents under axial and radial compression, axial tension, bending, and torsion deformations. J Mech Behav Biomed Mater. 2017;75:160–168.
6.
WernerMGomari-GrisarFBelalcazarS, et al. Prospective evaluation of the TIGRIS vascular stent within a modern treatment algorithm. J Endovasc Ther. 2019;26(5):637–642.
7.
PiorkowskiMFreitasBSteinerS, et al. Twelve-month experience with the GORE® TIGRIS® Vascular Stent in the superficial femoral and popliteal arteries. J Cardiovasc Surg (Torino). 2015;56:89–95.
8.
LucatelliPCiniMTommasinoG, et al. Use of the Gore Tigris Vascular Stent in advanced femoropopliteal peripheral arterial disease. J Vasc Interv Radiol. 2018;29:614–622.
9.
ScheinertDGrummtLPiorkowskiM, et al. A novel self-expanding interwoven nitinol stent for complex femoropopliteal lesions: 24-month results of the SUPERA SFA registry. J Endovasc Ther. 2011;18:745–752.
10.
YamawakiMHiranoKNakanoM, et al. Deployment of self-expandable stents for complex proximal superficial femoral artery lesions involving the femoral bifurcation with or without jailed deep femoral artery. Catheter Cardiovasc Interv. 2013;81:1031–1041.
11.
LairdJRZellerTLoeweC, et al. Novel nitinol stent for lesions up to 24 cm in the superficial femoral and proximal popliteal arteries: 24-month results from the TIGRIS randomized trial. J Endovasc Ther. 2018;25:68–78.
12.
SibéMKaladjiABoiratC, et al. French multicenter experience with the GORE TIGRIS Vascular Stent in superficial femoral and popliteal arteries. J Vasc Surg. 2017;5:1329–1335.
